超声特征与分子亚型预测乳腺癌TP53和PIK3CA基因体细胞突变
本研究在386例乳腺癌患者中开发并训练模型,利用临床病理与超声特征(二维及彩色多普勒)预测TP53和PIK3CA突变。超声钙化为TP53突变的独立预测因子,超声直径和超声类型为PIK3CA突变的独立预测因子;联合超声特征与分子亚型的多变量模型预测PIK3CA突变AUC达0.741(敏感度80.6%、特异度58.7%),验证集AUC=0.715;TP53突变模型AUC=0.653。
要点
- 超声钙化是乳腺癌TP53突变的独立预测因子(p<0.05)。
- 超声直径和超声类型是乳腺癌PIK3CA突变的独立预测因子(均p<0.05)。
- 联合超声特征与分子亚型预测PIK3CA突变,训练集AUC 0.741、验证集AUC 0.715。
核心结论
- 超声是无创识别乳腺癌TP53和PIK3CA突变存在的手段,联合超声特征与分子亚型的模型对预测基因突变、辅助个体化治疗决策具有意义。
研究设计与样本
- 在386例乳腺癌患者中开发并训练预测TP53和PIK3CA突变的模型,纳入临床病理及超声特征(二维和彩色多普勒超声),采用多变量逻辑回归分析构建联合模型,并在验证集中应用多变量模型。
关键影像表现/征象
- 超声上钙化是TP53突变的独立预测因子(p<0.05)。
- 超声上直径和超声类型是PIK3CA突变的独立预测因子(均p<0.05)。
诊断标准与关键数值
- Luminal B/HER2阳性、HER2阳性/ER阴性及三阴性乳腺癌亚型是TP53突变的强预测因子,OR分别为3.13、3.18、3.44(均p<0.05)。
- HER2阳性/ER阴性和三阴性乳腺癌亚型是PIK3CA突变的负向预测因子,OR分别为0.223、0.241(均p<0.05)。
- 联合超声特征与分子亚型的多变量模型预测PIK3CA突变,训练集AUC从0.553-0.610提高至0.741,敏感度80.6%、特异度58.7%。
- 多变量模型在验证集预测PIK3CA突变AUC=0.715。
- TP53突变预测模型AUC=0.653。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To predict mutations in TP53 and PIK3CA genes in breast cancer using ultrasound (US) signatures and clinicopathology.
MATERIALS AND METHODS: In this study, we developed and trained a model in 386 breast cancer patients to predict TP53 and PIK3CA mutations. The clinicopathological and US characteristics (including two-dimensional and color Doppler US) were investigated. Statistically significant variables were used to build predictive models, then a combined model was developed using the multivariate logistic regression analysis.
RESULTS: Univariate and multivariate analyses revealed that calcifications on US was an independent predictor of TP53 mutation (p < 0.05), whereas diameter on US and US type were independent predictors of PIK3CA mutation in breast cancer (all p < 0.05). Meanwhile, Luminal B/Human epidermal growth factor receptor two-positive (HER2+), HER2+/estrogen receptor-negative (ER-), and triple-negative breast cancer (TNBC) subtypes were strong predictors of TP53 mutation (odds ratio [OR] = 3.13, 3.18, 3.44, respectively, all p < 0.05). HER2+/ER- and TNBC subtypes were negative predictors of PIK3CA mutation (OR = 0.223, 0.241, respectively, all p < 0.05). The areas under curves (AUCs) for PIK3CA mutation in the training set increased from 0.553-0.610 to 0.741 in the multivariate model that combined US features and molecular subtype, with a sensitivity and specificity of 80.6% and 58.7%, respectively. The application of the multivariate model in the validation set achieved acceptable discrimination (AUC = 0.715). For TP53 mutation, the AUC was 0.653.
CONCLUSION: US is a non-invasive modality to recognize the presence of TP53 and PIK3CA mutation. The models combined with US features and molecular subtype have implications for the practical application of predicting gene mutation for individual decision-making regarding treatment planning.
引用
- Huang, Qiang, Jian, et al. Ultrasonic Features and Molecular Subtype Predict Somatic Mutations in TP53 and PIK3CA Genes in Breast Cancer. Acad Radiol. 2022. PMID: 35450798. doi:10.1016/j.acra.2022.02.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。